Medicines Evaluation Board, Netherlands

Top Publications

Top Publications Authored or Co-Authored in "Medicines Evaluation Board, Netherlands"

• Prediction of human drug-induced liver injury (DILI) in relation to oral doses and blood concentrations

  Archives of Toxicology, Volume 93, No. 6, Year 2019, Citations 79
• Evaluation of oncology drugs at the European Medicines Agency and US Food and Drug Administration: When differences have an impact on clinical practice

  Journal of Clinical Oncology, Volume 29, No. 16, Year 2011, Citations 67
• How do the EMA and FDA decide which anticancer drugs make it to the market? A comparative qualitative study on decision makers' views

  Annals of Oncology, Volume 25, No. 1, Year 2014, Citations 31
• Statistical approaches to indirectly compare bioequivalence between generics: A comparison of methodologies employing artemether/lumefantrine 20/120 mg tablets as prequalified by WHO

  European Journal of Clinical Pharmacology, Volume 68, No. 12, Year 2012, Citations 20
• Association Between the Occurrence of Adverse Drug Events and Modification of First-Line Highly Active Antiretroviral Therapy in Ghanaian HIV Patients

  Drug Safety, Volume 39, No. 11, Year 2016, Citations 16